Skip to content

Comprehensive treatment collateral disease of zoster associated pain

Effect of surround needling in combination with local injection on zoster associated pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020578
Enrollment
Unknown
Registered
2019-01-09
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

zoster associated pain

Interventions

surround Needling group:surround needling group were treated with needling at the Ashi points around the pain regions
local injection group:injected methylcobalamin combined with lidocainethe around the painful regions
surround needling in combination with local injection group:surround needling group were treated with needling at the Ashi points around the pain regions and injected methylcobalamin combined with li

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Subjects had to be aged 50 to 80 years; 2. A confirmed diagnosis of zoster associated pain; 3. VAS score of 4 or higher; 4. willingness to comply with the allocated treatment and follow-up measurements.

Exclusion criteria

Exclusion criteria: 1. cognitive impairment; 2. Combined with other primary or secondary peripheral nervous diseases; 3. Frustrated, rash-free herpes zoster; 4. any clinically significant medical conditioner or laboratory abnormality.

Design outcomes

Primary

MeasureTime frame
Zoster Brief Pain Inventory;visual analog scale;subcutaneous nerve fibers;Patients` Global Impression of Change;Quality of life;

Secondary

MeasureTime frame
Electrophysiological evaluation;

Countries

China

Contacts

Public ContactXu Gang

Shanghai Tenth People's Hospital

shsykfk@yeah.net+86 18917683646

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026